List of SBIR/STTR awards granted to Molecular Targeting Technologies
Molecular Targeting TechnologiesA SBIR Phase II contract was awarded to Molecular Targeting Technologies in September, 2022 for $999,389.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies in April, 2018 for $253,411.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $50,007.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies in August, 2017 for $214,174.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies in April, 2015 for $224,819.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Molecular Targeting Technologies for $162,433.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $222,581.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Molecular Targeting Technologies for $1,067,665.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase II contract was awarded to Molecular Targeting Technologies for $700,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $224,438.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $808,065.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase I contract was awarded to Molecular Targeting Technologies for $669,400.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $176,838.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase II contract was awarded to Molecular Targeting Technologies for $836,316.0 USD from the U.S. Department of Health & Human Services.
A STTR Phase II contract was awarded to Molecular Targeting Technologies for $2,509,160.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $193,511.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $219,935.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $196,224.0 USD from the U.S. Department of Health & Human Services.
A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $79,700.0 USD from the U.S. Department of Agriculture.
A SBIR Phase II contract was awarded to Molecular Targeting Technologies for $346,000.0 USD from the U.S. Department of Agriculture.
